Professor Thomas Powles MRCP MBBS MD is a director of Barts Cancer Centre and Professor of Urology Cancer at Barts Cancer Institute.

His background training includes Imperial College London and his MD thesis was in Mechanisms resistance to targeted therapy based at the University of London.

He has written over 200 in Uro-Oncology and Immune Oncology and given keynote presentations at key international meetings.

He has been involved in guidelines in testes, renal and bladder cancer.